Todos Medical Completes Acquisition of Key Assets and Intellectual Property from NLC Pharma
March 16, 2022 07:00 ET
|
Todos Medical Ltd.
- Forms new subsidiary, 3CL Pharma, focused on the development and commercialization of 3CL protease-related products including Tollovir™, Tollovid®, Tollovid Daily™ and TolloTest™ for COVID-19 - ...